Delta TpX Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Delta TpX General Information
Description
Developer of enzyme therapeutics intended to offer targeted cancer therapy. The company's therapeutics utilize optimized human enzymes to target the largely unexplored tumor small molecule immune messengers and microenvironment regulators that can be drivers of disease progression, enabling healthcare professionals to treat cancer patients whose tumors harbor the methylthioadenosine phosphorylase (MTAP) gene deletion.
Contact Information
Website
www.deltatpx.comCorporate Office
- 1601 Elm Street
- Suite 4360
- Dallas, TX 75201
- United States
Corporate Office
- 1601 Elm Street
- Suite 4360
- Dallas, TX 75201
- United States
Delta TpX Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 06-Mar-2023 | Completed | Out of Business | |||
| 2. Angel (individual) | 28-Jul-2021 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-2021 | Completed | Startup |
Delta TpX FAQs
-
When was Delta TpX founded?
Delta TpX was founded in 2019.
-
Where is Delta TpX headquartered?
Delta TpX is headquartered in Dallas, TX.
-
What industry is Delta TpX in?
Delta TpX’s primary industry is Biotechnology.
-
Is Delta TpX a private or public company?
Delta TpX is a Private company.
-
What is Delta TpX’s current revenue?
The current revenue for Delta TpX is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process